BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3463621)

  • 1. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
    Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumor markers in gynecologic diseases].
    Geyer H; Kleine W
    Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):168-72. PubMed ID: 3472991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M
    Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R; Kaesemann H; Caffier H
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical course and recurrence of human ovarian cancer by several serum tumor markers.
    Kikuchi Y; Kita T; Iwano I; Kuki E; Oomori K; Kizawa I
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):69-76. PubMed ID: 2926196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P; Wagner G
    Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor marker combination versus second-look operation in ovarian cancer].
    Lahousen M; Stettner H; Pürstner P; Pickel H
    Zentralbl Gynakol; 1990; 112(9):561-6. PubMed ID: 2378187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
    Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
    Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tumor markers in epithelial carcinoma of the ovary].
    Cottini M; Carnino F; Iskra L; Rapisarda V; Mossetti C
    Minerva Ginecol; 1986 Jun; 38(6):479-84. PubMed ID: 3461313
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
    Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
    Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
    Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
    Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
    Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
    Lücke R; Benz R; Kraus H
    Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):846-9. PubMed ID: 3481339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
    Göcze P; Vahrson H
    Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.